Cannabidiol modulation of hippocampal glutamate in early psychosis
Abstract Background: Emerging evidence supports the antipsychotic effect of cannabidiol, a non-intoxicating component of cannabis, in people with psychosis. Preclinical…
Abstract Background: Emerging evidence supports the antipsychotic effect of cannabidiol, a non-intoxicating component of cannabis, in people with psychosis. Preclinical…
Abstract With current trends in cannabis legalization, large efforts are being made to understand the effects of less restricted legislation…
Abstract Limited evidence has suggested that terpenes found in Cannabis sativa are analgesic, and could produce an “entourage effect” whereby…
Abstract In recent years, evidence has accumulated that cannabinoids—especially the non-psychoactive compound, cannabidiol (CBD)—possess promising medical and pharmacological activities that…
Abstract Fibroblast growth factors (FGFs) act as key signalling molecules in brain development, maintenance, and repair. They influence the intricate…
Abstract Acute exposure to cannabis has been associated with an array of cognitive alterations, increased risk for neuropsychiatric illness, and…
Abstract Parkinson’s disease (PD) is a major neurodegenerative disease (ND), presenting a progressive degeneration of the nervous system characterized by…
Abstract Over the past 25 years, cannabis plants have gained major popularity in the research community. This study aimed to…
Abstract Microglia, a type of innate immune cell of the brain, regulates neurogenesis, immunological surveillance, redox imbalance, cognitive and behavioral…
Abstract The use of the new psychoactive substances is continuously growing and the implementation of accurate and sensible analysis in…